BIMI International Medical Inc. (BIMI)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2022 | 7.65 Million USD | 189.95% |
| 2021 | 2.63 Million USD | 259.0% |
| 2020 | 735.35 Thousand USD | 3.93% |
| 2019 | 707.52 Thousand USD | -24.57% |
| 2018 | 937.96 Thousand USD | -54.56% |
| 2017 | 2.06 Million USD | -55.19% |
| 2016 | 4.6 Million USD | -34.67% |
| 2015 | 7.05 Million USD | 25.39% |
| 2014 | 5.62 Million USD | 112.37% |
| 2013 | 2.64 Million USD | 119.64% |
| 2012 | 1.2 Million USD | 107.43% |
| 2011 | 581.17 Thousand USD | -29.42% |
| 2010 | 823.39 Thousand USD | 28.9% |
| 2009 | 638.77 Thousand USD | -57.89% |
| 2008 | 1.51 Million USD | 4.72% |
| 2007 | 1.44 Million USD | -20.08% |
| 2006 | 1.81 Million USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q3 | 7.08 Million USD | -1.33% |
| 2023 Q1 | 8.46 Million USD | 10.6% |
| 2023 Q2 | 7.18 Million USD | -15.15% |
| 2022 Q3 | 1.23 Million USD | -59.37% |
| 2022 Q2 | 3.02 Million USD | 39.56% |
| 2022 FY | 7.65 Million USD | 189.95% |
| 2022 Q4 | 7.65 Million USD | 522.12% |
| 2022 Q1 | 2.16 Million USD | -17.81% |
| 2021 Q3 | 2.11 Million USD | -58.62% |
| 2021 FY | 2.63 Million USD | 259.0% |
| 2021 Q1 | 3.56 Million USD | 385.36% |
| 2021 Q2 | 5.11 Million USD | 43.36% |
| 2021 Q4 | 2.63 Million USD | 24.67% |
| 2020 Q3 | 4.19 Million USD | 66.28% |
| 2020 Q4 | 735.35 Thousand USD | -82.47% |
| 2020 Q2 | 2.52 Million USD | -21.06% |
| 2020 Q1 | 3.19 Million USD | 351.72% |
| 2020 FY | 735.35 Thousand USD | 3.93% |
| 2019 Q1 | 1.16 Million USD | 24.58% |
| 2019 FY | 707.52 Thousand USD | -24.57% |
| 2019 Q4 | 707.52 Thousand USD | -53.81% |
| 2019 Q3 | 1.53 Million USD | 32.65% |
| 2019 Q2 | 1.15 Million USD | -1.18% |
| 2018 Q1 | 3.06 Million USD | 48.35% |
| 2018 Q2 | 4.22 Million USD | 38.13% |
| 2018 FY | 937.96 Thousand USD | -54.56% |
| 2018 Q3 | 4.43 Million USD | 4.97% |
| 2018 Q4 | 937.96 Thousand USD | -78.87% |
| 2017 Q2 | 4.76 Million USD | -0.29% |
| 2017 Q1 | 4.77 Million USD | 3.75% |
| 2017 Q3 | 5.14 Million USD | 8.04% |
| 2017 Q4 | 2.06 Million USD | -59.91% |
| 2017 FY | 2.06 Million USD | -55.19% |
| 2016 Q1 | 6.05 Million USD | -14.11% |
| 2016 FY | 4.6 Million USD | -34.67% |
| 2016 Q2 | 5.97 Million USD | -1.4% |
| 2016 Q3 | 5.29 Million USD | -11.37% |
| 2016 Q4 | 4.6 Million USD | -12.96% |
| 2015 Q4 | 7.05 Million USD | -2.5% |
| 2015 Q3 | 7.23 Million USD | 7.32% |
| 2015 FY | 7.05 Million USD | 25.39% |
| 2015 Q2 | 6.73 Million USD | 5.16% |
| 2015 Q1 | 6.4 Million USD | 13.95% |
| 2014 Q2 | 2.99 Million USD | 0.53% |
| 2014 Q4 | 5.62 Million USD | 25.78% |
| 2014 Q1 | 2.97 Million USD | 12.39% |
| 2014 FY | 5.62 Million USD | 112.37% |
| 2014 Q3 | 4.47 Million USD | 49.43% |
| 2013 Q2 | 2.64 Million USD | 43.61% |
| 2013 Q3 | 2.91 Million USD | 10.36% |
| 2013 Q4 | 2.64 Million USD | -9.22% |
| 2013 FY | 2.64 Million USD | 119.64% |
| 2013 Q1 | 1.84 Million USD | 52.66% |
| 2012 Q1 | 856.09 Thousand USD | 47.3% |
| 2012 Q3 | 1.19 Million USD | 36.84% |
| 2012 Q2 | 876.82 Thousand USD | 2.42% |
| 2012 FY | 1.2 Million USD | 107.43% |
| 2012 Q4 | 1.2 Million USD | 0.47% |
| 2011 Q3 | 846.05 Thousand USD | -29.65% |
| 2011 FY | 581.17 Thousand USD | -29.42% |
| 2011 Q4 | 581.17 Thousand USD | -31.31% |
| 2011 Q2 | 1.2 Million USD | -6.74% |
| 2011 Q1 | 1.28 Million USD | 56.62% |
| 2010 Q3 | 1.58 Million USD | -19.59% |
| 2010 Q1 | 1.22 Million USD | 91.11% |
| 2010 Q4 | 823.39 Thousand USD | -47.99% |
| 2010 FY | 823.39 Thousand USD | 28.9% |
| 2010 Q2 | 1.96 Million USD | 61.28% |
| 2009 FY | 638.77 Thousand USD | -57.89% |
| 2009 Q2 | 837.78 Thousand USD | -61.31% |
| 2009 Q3 | 807.27 Thousand USD | -3.64% |
| 2009 Q1 | 2.16 Million USD | 42.78% |
| 2009 Q4 | 638.77 Thousand USD | -20.87% |
| 2008 Q2 | 1.43 Million USD | -14.33% |
| 2008 Q4 | 1.51 Million USD | -30.27% |
| 2008 FY | 1.51 Million USD | 4.72% |
| 2008 Q3 | 2.17 Million USD | 51.28% |
| 2008 Q1 | 1.67 Million USD | 15.88% |
| 2007 Q1 | 2.18 Million USD | 20.69% |
| 2007 Q4 | 1.44 Million USD | -13.29% |
| 2007 Q3 | 1.67 Million USD | 3.14% |
| 2007 FY | 1.44 Million USD | -20.08% |
| 2007 Q2 | 1.61 Million USD | -25.95% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q4 | 1.81 Million USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 FY | 1.81 Million USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | - USD | -Infinity% |
| China Jo-Jo Drugstores, Inc. | 17.16 Million USD | 55.403% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 10.86 Million USD | 29.564% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 10.86 Million USD | 29.564% |
| Leafly Holdings, Inc. | - USD | -Infinity% |
| Leafly Holdings, Inc. | - USD | -Infinity% |
| LifeMD, Inc. | 2.75 Million USD | -177.334% |
| LifeMD, Inc. | 2.75 Million USD | -177.334% |
| TRxADE HEALTH, Inc. | 968.00 USD | -790627.479% |
| PetMed Express, Inc. | 28.55 Million USD | 73.196% |
| Walgreens Boots Alliance, Inc. | 8.32 Billion USD | 99.908% |